Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2023Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse modelNguyen, H.T.; Venter, H.; Woolford, L.; Young, K.A.; McCluskey, A.; Garg, S.; Sapula, S.S.; Page, S.W.; Ogunniyi, A.; Trott, D.J.; Leggett, J.E.
2019Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-Amine with antibiotic activityRussell, C.C.; Stevens, A.; Young, K.A.; Baker, J.R.; McCluskey, S.N.; Khazandi, M.; Pi, H.; Ogunniyi, A.; Page, S.W.; Trott, D.J.; McCluskey, A.
2019In vitro antimicrobial activity of robenidine, ethylenediaminetetraacetic acid and polymyxin B nonapeptide against important human and veterinary pathogensKhazandi, M.; Pi, H.; Chan, W.Y.; Ogunniyi, A.D.; Sim, J.X.F.; Venter, H.; Garg, S.; Page, S.W.; Hill, P.B.; McCluskey, A.; Trott, D.J.
2018Gram-positive and gram-negative antibiotic activity of asymmetric and monomeric robenidine analoguesRussell, C.C.; Stevens, A.; Pi, H.; Khazandi, M.; Ogunniyi, A.; Young, K.A.; Baker, J.R.; McCluskey, S.N.; Page, S.W.; Trott, D.J.; McCluskey, A.
2019Aminoguanidines: new leads for treatment of Giardia duodenalis infectionAbraham, R.J.; Abraham, S.; Stevens, A.J.; Page, S.W.; McCluskey, A.; Trott, D.J.; O'Handley, R.M.
2022Impact of a novel anticoccidial analogue on systemic staphylococcus aureus infection in a bioluminescent mouse modelNguyen, H.T.; Venter, H.; Woolford, L.; Young, K.; McCluskey, A.; Garg, S.; Page, S.W.; Trott, D.J.; Ogunniyi, A.D.
2022In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative PathogensPi, H.; Venter, H.; Russell, C.C.; Young, K.A.; McCluskey, A.; Page, S.W.; Ogunniyi, A.D.; Trott, D.J.